Oxbridge Re (OXBR) Expected to Announce Earnings on Tuesday

Oxbridge Re (NASDAQ:OXBR) is anticipated to announce its Q4 2025 results after the market closes on Tuesday, March 31st. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $0.70 million for the quarter. Investors can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Monday, March 30, 2026 at 4:30 PM ET.

Oxbridge Re Stock Down 2.7%

NASDAQ OXBR opened at $0.92 on Tuesday. Oxbridge Re has a fifty-two week low of $0.76 and a fifty-two week high of $2.86. The business has a fifty day moving average of $1.07 and a 200-day moving average of $1.42. The stock has a market cap of $7.08 million, a price-to-earnings ratio of -2.71 and a beta of 2.27.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Oxbridge Re in a research report on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $5.00.

Hedge Funds Weigh In On Oxbridge Re

A hedge fund recently raised its stake in Oxbridge Re stock. J.W. Cole Advisors Inc. grew its stake in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR) by 106.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 68,000 shares of the insurance provider’s stock after buying an additional 35,000 shares during the period. J.W. Cole Advisors Inc. owned 0.89% of Oxbridge Re worth $90,000 as of its most recent SEC filing. 5.64% of the stock is owned by institutional investors.

About Oxbridge Re

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.